Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men - Spratt, JC; Goddard, J; Patel, N (Br J Pharmacol, 2001)
et al.